{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:38Z","timestamp":1792725218512,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["95168 4"],"award-info":[{"award-number":["95168 4"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bbrc.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T01:56:01Z","timestamp":1667786161000},"page":"32-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Selection and characterization of a new human Interleukin-17A blocking DNA aptamer using protein-SELEX"],"prefix":"10.1016","volume":"637","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6642-7400","authenticated-orcid":false,"given":"Saeideh Sadat","family":"Shobeiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0036-0087","authenticated-orcid":false,"given":"Kazem","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motahareh","family":"Khorrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-6431","authenticated-orcid":false,"given":"Mojtaba","family":"Sankian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.11.005_bib1","series-title":"A\u00a0Review of Aptamer-Based SERS Biosensors: Design Strategies and Applications","author":"Muhammad","year":"2021"},{"key":"10.1016\/j.bbrc.2022.11.005_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108326","article-title":"Plaque-type psoriasis inhibitors","volume":"101","author":"Shobeiri","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40257-015-0162-4","article-title":"Anti-IL-17 medications used in the treatment of plaque psoriasis and psoriatic arthritis: a comprehensive review","volume":"17","author":"Canavan","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.bbrc.2022.11.005_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cei.13449","article-title":"IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa","volume":"201","author":"Fletcher","year":"2020","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-021-00401-3","article-title":"Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist","volume":"22","author":"Li","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bbrc.2022.11.005_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2017.01.016","article-title":"Interluekin-17A (IL17A)","volume":"614","author":"Chen","year":"2017","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14712598.2019.1554053","article-title":"Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis","volume":"19","author":"Wendling","year":"2019","journal-title":"Expet Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/09546634.2017.1329511","article-title":"Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease","volume":"29","author":"Hohenberger","year":"2018","journal-title":"J.\u00a0Dermatol. Treat."},{"issue":"12","key":"10.1016\/j.bbrc.2022.11.005_bib9","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1039\/D0AN00460J","article-title":"Productive screening of single aptamers with ddPCR","volume":"145","author":"Chen","year":"2020","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.bbrc.2022.11.005_bib10","first-page":"BE01","article-title":"Aptamers in therapeutics","volume":"10","author":"Parashar","year":"2016","journal-title":"J.\u00a0Clin. Diagn. Res.: J. Clin. Diagn. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s10753-016-0477-1","article-title":"Aptamers against pro-and anti-inflammatory cytokines: a review","volume":"40","author":"Boshtam","year":"2017","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.bbrc.2022.11.005_bib12","doi-asserted-by":"crossref","first-page":"e2969","DOI":"10.1002\/btpr.2969","article-title":"Designing a new dimerized anti human TNF-\u03b1 aptamer with blocking activity","volume":"36","author":"Mashayekhi","year":"2020","journal-title":"Biotechnol. Prog."},{"issue":"12","key":"10.1016\/j.bbrc.2022.11.005_bib13","doi-asserted-by":"crossref","first-page":"20979","DOI":"10.3390\/molecules201219739","article-title":"DNA aptamers in the diagnosis and treatment of human diseases","volume":"20","author":"Zhu","year":"2015","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bbrc.2022.11.005_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s12094-017-1629-y","article-title":"Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas","volume":"19","author":"Sett","year":"2017","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bbrc.2022.11.005_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2013.12.031","article-title":"Optimization of SELEX: comparison of different methods for monitoring the progress of in\u00a0vitro selection of aptamers","volume":"91","author":"Mencin","year":"2014","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.bbrc.2022.11.005_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.trsl.2016.12.008","article-title":"DNA aptamer probes for detection of estrogen receptor \u03b1 positive carcinomas","volume":"183","author":"Sett","year":"2017","journal-title":"Transl. Res."},{"issue":"12","key":"10.1016\/j.bbrc.2022.11.005_bib17","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3390\/molecules22122070","article-title":"Development of cell-specific aptamers: recent advances and insight into the selection procedures","volume":"22","author":"Rahimizadeh","year":"2017","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.bbrc.2022.11.005_bib18","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/molecules24234229","article-title":"Aptamers: a review of their chemical properties and modifications for therapeutic application","volume":"24","author":"Adachi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2022.11.005_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.intimp.2016.04.042","article-title":"Cell-SELEX-based selection and characterization of a G-quadruplex DNA aptamer against mouse dendritic cells","volume":"36","author":"Moghadam","year":"2016","journal-title":"Int. Immunopharm."},{"issue":"7","key":"10.1016\/j.bbrc.2022.11.005_bib20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biochi.2011.04.003","article-title":"Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A\/F","volume":"93","author":"Adachi","year":"2011","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib21","first-page":"86","article-title":"Truncation of PDGF-BB aptamer by secondary structural analysis and immunoassay","volume":"5","author":"Vu","year":"2016","journal-title":"Int J Pharm Med Biol Sci"},{"key":"10.1016\/j.bbrc.2022.11.005_bib22","unstructured":"Mahil, S., et\u00a0al., Comparing the Efficacy and Tolerability of Biologic Therapies in Psoriasis."},{"issue":"9","key":"10.1016\/j.bbrc.2022.11.005_bib23","doi-asserted-by":"crossref","DOI":"10.5070\/D3249041420","article-title":"The successful treatment with ixekizumab in a multi-failure psoriasis patient","volume":"24","author":"Azevedo","year":"2018","journal-title":"Dermatol. Online J."},{"issue":"2","key":"10.1016\/j.bbrc.2022.11.005_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/art.30108","article-title":"Therapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models","volume":"63","author":"Ishiguro","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2022.11.005_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejmech.2012.07.045","article-title":"Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA","volume":"56","author":"Zhu","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1146\/annurev.biochem.68.1.611","article-title":"In\u00a0vitro selection of functional nucleic acids","volume":"68","author":"Wilson","year":"1999","journal-title":"Annu. Rev. Biochem."},{"issue":"13","key":"10.1016\/j.bbrc.2022.11.005_bib27","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1093\/nar\/17.13.4937","article-title":"Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support","volume":"17","author":"Hultman","year":"1989","journal-title":"Nucleic Acids Res."},{"issue":"20","key":"10.1016\/j.bbrc.2022.11.005_bib28","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1073\/pnas.85.20.7652","article-title":"Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus","volume":"85","author":"Gyllensten","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.bbrc.2022.11.005_bib29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s11274-010-0563-8","article-title":"Conditions optimized for the preparation of single-stranded DNA (ssDNA) employing lambda exonuclease digestion in generating DNA aptamer","volume":"27","author":"Citartan","year":"2011","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.bbrc.2022.11.005_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1346-8138.14096","article-title":"Safety of biologics in psoriasis","volume":"45","author":"Kamata","year":"2018","journal-title":"J.\u00a0Dermatol."},{"issue":"1","key":"10.1016\/j.bbrc.2022.11.005_bib31","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.893","article-title":"Anti-IL-23 and Anti-IL-17 biologic agents for the treatment of immune-mediated inflammatory conditions","volume":"103","author":"Frieder","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bbrc.2022.11.005_bib32","doi-asserted-by":"crossref","first-page":"11959","DOI":"10.3390\/molecules200711959","article-title":"A\u00a0highlight of recent advances in aptamer technology and its application","volume":"20","author":"Sun","year":"2015","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bbrc.2022.11.005_bib33","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22015339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22015339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:58:03Z","timestamp":1777377483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22015339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":33,"alternative-id":["S0006291X22015339"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.11.005","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection and characterization of a new human Interleukin-17A blocking DNA aptamer using protein-SELEX","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}